As per our new research report “ US Diagnostic Market Outlook 2014”, the diagnostic and disease management improvements offered by new medical imaging systems over earlier generation equipment have been quite substantial in the US diagnostics industry for the past few years. Our study indicates that, the market has been strongly supported by equipments, such as computed tomography (CT) and MRI with each registering annual gains of at least 9.0% during the last 2-3 years.
Further, technological advances in MRI systems have improved both performance capabilities and patient comfort. Newer models include the mobile intraoperative MRI (iMRI), and image-guided scanner used for surgery. The latest innovations to reach the market are high field, open-sided scanners that offer enhanced anatomical images and shorter testing times and larger-bore platforms for obese or claustrophobic patients.
Besides, we have done thorough research and prudent analysis of the US diagnostics industry and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that, the US IVD industry is already in a pivotal position to secure a significant share in the healthcare industry. The main reason for bright prospects are prevalence of several chronic and infectious diseases, emergence of technologies in molecular diagnostics, point-of-care testing, and spreading of awareness among health professionals and patients.
As per our research on the industry, the molecular diagnostic tests will be a major growth driver of the industry in near future due to the increasing consumer awareness about health concerns. The demand for highly technological innovative tests will increase as they are capable of providing more precise results.
The report “ US Diagnostic Market Outlook 2014” evaluates the US diagnostic market potentials and identifies future growth opportunities. The report provides extensive research and analysis on current market trends and future forecasts on all prominent diagnostic techniques including POCT, clinical chemistry, immunoassays, blood testing, and molecular diagnostics. Further, the report facilitates information/statistics on market developments in laboratory applications and disease indications. Projections made on market future scenario will help clients to take informed and proactive business decisions in the fast growing US diagnostic market.
For more information visit: http://www.rncos.com/Report/IM298.htm |
